Partners4Access

We believe in a sustainable orphan drug, cell & gene therapy world. We partner with biotech firms to support their drug launch journey.

[Partners4Access @Partners4A]

https://t.co/oUI2BcEkvb

[Partners4Access @Partners4A]

Listen to "One on One with Alejandro Dorenbaum, CMO at Reneo Pharmaceuticals" by P4A Let's Talk Rare. https://t.co/lIkQ4efPXR

[Partners4Access @Partners4A]

Are YOU ready for EU HTA implementation in 2025? - https://t.co/yrAmHPkpVq

[Partners4Access @Partners4A]

Are YOU ready for EU HTA implementation in 2025? - https://t.co/1gsuQI9bBV

[Partners4Access @Partners4A]

https://t.co/eUQ0IYoTIT

[Partners4Access @Partners4A]

I'm fundraising for Genetic Alliance UK - Rare Disease UK. Check out my @JustGiving page and please donate if you can. Thank you! #JustGiving https://t.co/ItNN3Ajxvo

[Partners4Access @Partners4A]

A normal day in the P4A office :)
Loved learning this routine and performing with the best team in the business! P4A Rocks! https://t.co/Hl6NvR1XH9

[Partners4Access @Partners4A]

Listen to "Interview with Xortx Therpeutics CEO, Dr Allen Davidoff discussing their commercial journey from early development to launch" by P4A Let's Talk Rare. https://t.co/BQVYZakHlo

[Partners4Access @Partners4A]

Welcome to the P4A family Aurelija Luko :) https://t.co/fejgjcJqS3

[Partners4Access @Partners4A]

Our analysts are hard at work completing the #BOBIawards. We entered the category of 'Analyst Team of the Year' and they received the challenge at 0730 this morning!

Good luck to everyone who has entered and fingers crossed for our amazing analysts Priya…https://t.co/5QwVkDb43u

[Partners4Access @Partners4A]

https://t.co/SRdQHshRDI

[Partners4Access @Partners4A]

We had such a good night, bonding together as a team. I love working at Partners4Access! Now we are getting ready conference season next week! We will be in Boston and Amsterdam for @6th gene therapy for rare disorders and @totalbiopharma and really looki…https://t.co/EDFsQ7v7eT

[Partners4Access @Partners4A]

Congratulations to Novartis! https://t.co/xzxUCnWrxM

[Partners4Access @Partners4A]

Congratulations to Cure & Action for Tay-Sachs (CATS) Foundation for winning our 'Best Patient Advocacy Group' award! We also have one of the founders Daniel Lewi coming on a guest on our Rare Disease Day Special episode, which will be released on Rare Di…https://t.co/wDXCypBaBR

[Partners4Access @Partners4A]

Looking forward to seeing the results on Friday :) https://t.co/2QkLmEtJNr

[Partners4Access @Partners4A]

Listen to "World Orphan Drug Congress Europe 2022 Special" by P4A Let's Talk Rare. ⚓ https://t.co/gDbUVN131e

[Partners4Access @Partners4A]

If you are attending #WODCEU2022, here are 3 roundtables you don't want to miss! https://t.co/fk5PavOfGz

[Partners4Access @Partners4A]

https://t.co/mtoLs7G2le

[Partners4Access @Partners4A]

Listen to "Winds of change for German Healthcare Market!" by P4A Let's Talk Rare. ⚓ https://t.co/GKjPRizu19

[Partners4Access @Partners4A]

P4A Patient & Caregiver Advisory Council - https://t.co/ciw5p2c7Li